The healthcare industry includes companies that sell drugs, medical equipment, and insurance, as well as hospitals and healthcare providers. Since their rapidly increasing values during the pandemic, the healthcare industry has attracted the attention of investors. This is because some of these companies have obtained regulatory approvals from the government for the drugs for the treatment of COVID19 and started distributing vaccines, while others are eager to develop new COVID19 drugs and obtain approval for theirs. There are also companies involved in various other ways, such as offering products to test and administer viral treatments. Let’s talk about the top 5 healthcare stocks with the best value, the fastest growth, and the most momentum. to invest in 2021
1. Agios pharmaceuticals
Agios is a currently clinical-stage biopharmaceutical company that primarily provides therapies in the field of cancer metabolism and also develops drugs that target glycolysis, fatty acid metabolism, and autophagy for the same. On June 21, the company submitted a new drug application (NDA) for mitapivat to the US Food and Drug Administration, which aims to treat pyruvate kinase (PK) deficiency in adults, which can lead to fatigue.
2. BioRad Laboratories Inc.
BioRad is a manufacturer of life science research products and related analytical instruments which are used to separate and analyze different complex chemical and biological compounds for the development of drugs.
3. Sage Therapeutics Inc.
Sage Therapeutics is mainly involved in providing treatments for central nervous system diseases, including schizophrenia and major depression. The company reported that trials of its drug SAGE718 made positive progress in the first quarter of 2021. The drug may be used to treat Huntington’s disease, a progressive brain disease that affects sports, cognitive, and mental health.
4. Moderna Inc.
Currently, Moderna Inc. is a clinical-stage biotech company that primarily focuses on discovering and developing messenger RNA therapeutics and vaccines for the Covid pandemic. Its primary role is developing medicines and vaccines for infectious, immuno-oncology, and cardiovascular diseases. This year, during the pandemic, starting from mid-June, the U.S. government has bought about 200 million doses of the company’s COVID-19 vaccine, increasing its value rapidly.
5. PPD Inc
PPD or Pharmaceutical Product Development is a global contract research organization and primarily engages in drug discovery, laboratory services, clinical development, lifecycle management, and so on. It extends its services to sectors like- pharmaceutical, biotechnology, medical devices, and government organizations
Edited by Tanish Sachdev